Wheat Bread Study: Comparison of the Tolerance of Different Wheat Breads
Launched by UNIVERSITY OF HOHENHEIM · Nov 28, 2023
Trial Information
Current as of November 05, 2025
Recruiting
Keywords
ClinConnect Summary
The Wheat Bread Study is looking at how different types of wheat bread affect people who may have sensitivities to wheat. If you have symptoms like stomach pain or discomfort after eating wheat, this study might be for you. Researchers want to see if certain breads are easier to tolerate than others and whether not having a reaction to these breads means there are no harmful changes in the gut lining.
To participate, you need to be between 18 and 75 years old and have experienced ongoing stomach issues for at least six months. You should also have a history of wheat sensitivity but not have any major gastrointestinal diseases like celiac disease. During the study, you’ll be asked to follow a specific diet and will be monitored to see how your body responds to different breads. This research aims to help better understand wheat sensitivity and improve dietary options for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 ≤75 years
- • Signed declaration of consent
- • Willingness to adhere to the prescribed diet for the duration of the study
- • Chronic gastrointestinal symptoms for at least 6 months
- • Anamnestic wheat sensitivity
- • No acute or chronic gastrointestinal diseases (e.g. celiac disease / wheat allergy)
- • No or stable medication for at least 3 months
- • No participation in another clinical trial (current or within the past 30 days)
- Exclusion Criteria:
- • Taking intestinal therapeutics, antibiotics, immunosuppressants, anti-allergic medication or similar
- • Pregnancy / lactation
- • Occurrence of relevant diseases (possibly individual decision)
- • Revocation of consent
- • Concurrent participation in another clinical study
About University Of Hohenheim
The University of Hohenheim, a leading institution in agricultural and environmental sciences based in Germany, is dedicated to advancing research and innovation in health-related fields. With a strong emphasis on interdisciplinary collaboration, the university conducts clinical trials that aim to improve patient outcomes and contribute to the scientific community's understanding of various health conditions. Leveraging its world-class facilities and expertise, the University of Hohenheim is committed to ensuring rigorous compliance with ethical standards and regulatory requirements, fostering an environment of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stuttgart, Germany
Stuttgart, Baden Württemberg, Germany
Lübeck, Schleswig Holstein, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported